Emily A L Stockings1, Jenny A Bowman2, Amanda L Baker3, Margarett Terry4, Richard Clancy3, Paula M Wye5, Jenny Knight6, Lyndell H Moore7, Maree F Adams7, Kim Colyvas7, John H Wiggers5. 1. University of Newcastle, Callaghan, New South Wales, Australia; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; e.stockings@unsw.edu.au. 2. University of Newcastle, Callaghan, New South Wales, Australia; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; 3. University of Newcastle, Callaghan, New South Wales, Australia; Centre for Translational Neuroscience and Mental Health, Mater Hospital, Waratah, New South Wales, Australia; 4. Mental Health and Substance Use Service, Mater Hospital, Waratah, New South Wales, Australia; 5. University of Newcastle, Callaghan, New South Wales, Australia; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia; Hunter New England Population Health, Wallsend, New South Wales, Australia. 6. Hunter New England Population Health, Wallsend, New South Wales, Australia. 7. University of Newcastle, Callaghan, New South Wales, Australia;
Abstract
INTRODUCTION:Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden compared with the general population. The aim of this study was to determine if a smoking cessation intervention initiated during a psychiatric hospitalization and continued postdischarge was effective in reducing smoking behaviors among persons with a mental disorder. METHODS: A randomized controlled trial was conducted at an Australian inpatient psychiatric facility. Participants were 205 patient smokers allocated to a treatment as usual control (n = 101) or a smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for 4 months postdischarge. Follow-up assessments were conducted at 1 week, 2, 4, and 6 months postdischarge and included abstinence from cigarettes, quit attempts, daily cigarette consumption, and nicotine dependence. RESULTS:Rates of continuous and 7-day point prevalence abstinence did not differ between treatment conditions at the 6-month follow-up; however, point prevalence abstinence was significantly higher for intervention (11.5%) compared with control (2%) participants at 4 months (OR = 6.46, p = .01). Participants in the intervention condition reported significantly more quit attempts (F[1, 202.5] = 15.23, p = .0001), lower daily cigarette consumption (F[4, 586] = 6.5, p < .001), and lower levels of nicotine dependence (F[3, 406] = 8.5, p < .0001) compared with controls at all follow-up assessments. CONCLUSIONS: Postdischarge cessation support was effective in encouraging quit attempts and reducing cigarette consumption up to 6 months postdischarge. Additional support strategies are required to facilitate longer-term cessation benefits for smokers with a mental disorder.
RCT Entities:
INTRODUCTION:Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden compared with the general population. The aim of this study was to determine if a smoking cessation intervention initiated during a psychiatric hospitalization and continued postdischarge was effective in reducing smoking behaviors among persons with a mental disorder. METHODS: A randomized controlled trial was conducted at an Australian inpatient psychiatric facility. Participants were 205 patient smokers allocated to a treatment as usual control (n = 101) or a smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for 4 months postdischarge. Follow-up assessments were conducted at 1 week, 2, 4, and 6 months postdischarge and included abstinence from cigarettes, quit attempts, daily cigarette consumption, and nicotine dependence. RESULTS: Rates of continuous and 7-day point prevalence abstinence did not differ between treatment conditions at the 6-month follow-up; however, point prevalence abstinence was significantly higher for intervention (11.5%) compared with control (2%) participants at 4 months (OR = 6.46, p = .01). Participants in the intervention condition reported significantly more quit attempts (F[1, 202.5] = 15.23, p = .0001), lower daily cigarette consumption (F[4, 586] = 6.5, p < .001), and lower levels of nicotine dependence (F[3, 406] = 8.5, p < .0001) compared with controls at all follow-up assessments. CONCLUSIONS: Postdischarge cessation support was effective in encouraging quit attempts and reducing cigarette consumption up to 6 months postdischarge. Additional support strategies are required to facilitate longer-term cessation benefits for smokers with a mental disorder.
Authors: Patrick J Hammett; Harry A Lando; Darin J Erickson; Rachel Widome; Brent C Taylor; David Nelson; Sandra J Japuntich; Steven S Fu Journal: J Behav Med Date: 2019-07-30
Authors: Marc L Steinberg; Jill M Williams; Naomi F Stahl; Patricia Dooley Budsock; Nina A Cooperman Journal: Nicotine Tob Res Date: 2015-03-05 Impact factor: 4.244
Authors: Alexandra P Metse; John Wiggers; Paula Wye; Lyndell Moore; Richard Clancy; Luke Wolfenden; Megan Freund; Tara Van Zeist; Emily Stockings; Jenny A Bowman Journal: BMC Public Health Date: 2016-04-14 Impact factor: 3.295
Authors: Alexandra P Metse; Jenny A Bowman; Paula Wye; Emily Stockings; Maree Adams; Richard Clancy; Margarett Terry; Luke Wolfenden; Megan Freund; John Allan; Judith J Prochaska; John Wiggers Journal: Trials Date: 2014-07-05 Impact factor: 2.279